Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

RELEASE DATE
07-Mar-2013
REGION
North America
Deliverable Type
Market Research
Research Code: 9561-00-F3-00-00
SKU: LS00245-NA-MR_17659
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
LS00245-NA-MR_17659

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies.

Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.

Table of Contents

This week's issue

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies. Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
WIP Number 9561-00-F3-00-00
Is Prebook No